Theralink Technologies, Inc. (THER)

Market Cap	6.15K -99.9%
Revenue (ttm)	635.45K +16.8%
Net Income	-13.50M
EPS	-0.00
Shares Out	6.15B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,500,000
Average Volume	478,739
Open	0.0000
Previous Close	0.0000
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0010
Beta	65.19
RSI	43.15
Earnings Date	n/a

About Theralink Technologies

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of oncology products in the United States. The company offers patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It also provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying...

• Industry: Biotechnology
• Sector: Healthcare
• Employees: 16
• Stock Exchange: OTCMKTS
• Ticker Symbol: THER

Financial Performance

In fiscal year 2023, Theralink Technologies's revenue was $606,796, an increase of 6.85% compared to the previous year's $567,905. Losses were -$30.95 million, 138.4% more than in 2022.